Navigation Links
Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
Date:1/26/2012

RALEIGH, N.C., Jan. 26, 2012 /PRNewswire/ -- Lend Lease is pleased to announce the appointment of Tom Chapman as Director of Operations for the Life Sciences group in the Atlantic Region.  Tom rejoined Lend Lease on January 4, 2012, and will be based out of the Raleigh, NC office, working closely with the regional office heads and business development teams in the South Atlantic offices. He will report directly to Steve Eberling, Senior Vice President, Principal In Charge, Life Sciences and Princeton.

Tom has been in the Design and Construction industry  for over 33 years and has focused his career specifically on the  Life Science sector for the last 22 years. During this time, Tom has worked for Day & Zimmerman / Life Sciences for 8 Years, Turner Construction for 6 Years and most recently Jacobs for the past 9 years.   Prior to working at Jacobs, Tom worked for the legacy Bovis Lend Lease business within the Global Life Sciences Group in the Princeton, NJ office. 

Tom has completed mechanical design and engineering, and engineering courses from Villanova and Temple Universities and received a master certificate PMP project management from Villanova University.  His numerous professional affiliations include International Society for Pharmaceutical Engineering (ISPE) Delaware Valley Chapter, Design Build Institute of America, Project Management Institute and the Drexel University Construction Management Advisory Committee.

About Lend Lease

Lend Lease is a leading international property and infrastructure group. Listed on the Australian Securities Exchange and with circa 17,000 employees worldwide, Lend Lease's capabilities span the property and infrastructure spectrum.

The Americas region headquarters is located in New York. In the Americas we offer project management & construction, public partnerships, public-private partnerships, development and asset & pr
'/>"/>

SOURCE Lend Lease
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
2. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
3. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
4. Verify Brand™ Announces the Release of VB Enterprise 4.0
5. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
6. ICD-10 Coding Knowledge Assessment Tool Released
7. Dyadic International Announces Date and Time of Third Quarter 2011 Financial Results Release and Conference Call
8. Minimally Invasive Devices, Inc. Announces Release of FloShield™ PLUS
9. Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
10. STAAR Surgical Announces Third Quarter 2011 Results Release Date and Conference Call
11. Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TEL AVIV, Israel , May 4, 2015 /PRNewswire/ ... has filed its annual report on Form 20-F for ... U.S. Securities and Exchange Commission ("SEC"). The annual report ... for the development of antibodies in the area of ... antibodies with superior qualities of high specificity and binding ...
(Date:5/4/2015)... 2015 /PRNewswire/ - The Fight Against Cancer Innovation ... announce the formation of Turnstone Biologics Inc. (Turnstone), ... cancer that harness the patient,s own immune system. ... between the Children,s Hospital of Eastern ... the Ontario Institute for Cancer Research (OICR), the ...
(Date:5/4/2015)... Achieved primarily through a proprietary paraffin ... 10 to 100x better detail than the industry standard. ... existing light microscopy methods, it needed another medium to ... the frame of reference because it represents the highest ... from the earliest discovery days of Ultralight Histology was ...
(Date:5/4/2015)... , May 4, 2015 ... thousands of med students prepare for the United States ... world-leading provider of scientific, technical and medical information products ... free MOOC (Massive Open Online Course) designed to help ... Examination (USMLE) Step 1, the first and most daunting ...
Breaking Biology Technology:Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3
... ... enhance greenhouse gas reduction on the local level , , ... Marlborough, MA (PRWEB) October 24, 2009 -- Over forty employees at ... International Day of Climate Action , October 24, 2009. Climate Change awareness actions such as ...
... - Dr. Brad Thompson, President and CEO of Oncolytics ... present a corporate overview of the Company at the ... 28, 2009 at 3:00 p.m. PT. The conference will ... on October 28 and 29, 2009. , A live ...
... YORK, Oct. 23 Pulmo BioTech Inc. (OTC ... that it will ultimately receive at least $3.3 ... the previously announced non-binding letter of intent with ... its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) development ...
Cached Biology Technology:Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009 2Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009 3Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009 2Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market 2Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market 3Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market 4
(Date:4/27/2015)... Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... pre-order customers the first week of May, 2015 and ... of May. Gino Pereira , ... for the company as Wocket® enters the consumer market. ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... trackway with 12 consecutive prints provides the most compelling ... trackway, located in La Virgen del Campo track site ... continuous record of swimming by a non-avian therapod dinosaur. ... Patrimonio Paleontológico de La Rioja, La Rioja, Spain, discovered ...
... new gene therapy can nearly eliminate arthritis pain, and ... to a study published today in the journal Arthritis ... they are the first genetically engineered to develop osteoarthritis ... some more likely to develop the disease, the authors ...
... of Central and South America conduct spectacular predatory raids containing ... bodies to plug potholes in the trail leading back to ... be delivered to the developing young at maximum speed. , ... trail of forager traffic, along which prey-laden foragers run back ...
Cached Biology News:Definitive evidence found of a swimming dinosaur 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4Ants show us how to make super-highways 2
... were designed for full-length gene cloning and ... identify the desired cDNA clone. The first ... "Master Plate," where each well contains plasmid ... positive well(s) by gel electrophoresis of the ...
... Preparation Note: Prepared by a modification ... et al., Biotechnol. Bioeng., ... One unit will yield an A ... ml of water (1 cm light ...
... Cleland’s Reagent, Immobilized White solid. PACKAGED ... of DTT on polyacrylamide resin with applications similar ... 233153 , 233156 , and 233155 ... soluble components are added to the system. REDUCTACRYL™ ...
... The Yeast Whole Genome ChIP-on-chip Microarray ... of yeast (S. cerevisiae) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
Biology Products: